Orthofix International | OFIX - Cost Of Sales


Orthofix International reported $66.63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 34.98M 3.04M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
EDAP TMS EUR 9.67M 1.76M Mar/2026
Globus Medical USD 271M 7.41M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
J&J USD 8B 67M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Smith & Nephew USD 901M 31M Jun/2026
STAAR Surgical USD 23.81M 855K Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Veracyte USD 42.19M 3.7M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026